Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003
about
The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan.Epidemiology of invasive candidiasis: a persistent public health problemTriazole Resistance in Aspergillus Species: An Emerging Problem.Treatment of cryptococcosis in the setting of HIV coinfection.Antifungal susceptibilities of Candida isolates causing bloodstream infections at a medical center in Taiwan, 2009-2010In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methodsCryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus.Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testingVoriconazole in the management of nosocomial invasive fungal infections.Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in AsiaIncreasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal studyIn vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates.Analysis of the genetic diversity of Candida isolates obtained from diabetic patients and kidney transplant recipients.Efflux-mediated antifungal drug resistance.Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location in the United States in 2001 to 2007.Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients.The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro.Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Fungicidal photodynamic effect of a twofold positively charged porphyrin against Candida albicans planktonic cells and biofilms.Mechanisms of azole resistance in a clinical isolate of Candida tropicalis.Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment.Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections.Azole-resistant Aspergillus fumigatus isolates carrying TR₃₄/L98H mutations in Taiwan.Species distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999-2006.Antimicrobial activities of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi.Triazole Resistance in Aspergillus spp.: A Worldwide Problem?Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies.In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs.Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009.Zeocin resistance as a dominant selective marker for transformation and targeted gene deletions in Candida glabrata.Azole-Resistant Invasive Aspergillosis: Relationship to Agriculture
P2860
Q24814052-F9086CFF-0C09-4CB5-8622-9D0B29628B26Q29616758-158B32D1-F4E7-4E23-80C4-21EDC893C67BQ30235566-06B26F62-0CA5-4827-A1CA-C79671E20C21Q30366117-9E0B9154-273A-4CBE-9206-08D399B6C6EAQ33798413-9A7A56F1-9689-4158-9152-33A395AB1E28Q34041745-29F30275-D1C4-4CF4-ABB4-0AB35844D783Q34298083-0359E51B-9812-4F87-9F42-52BA148AC75DQ34452089-0E2BE5A8-5F33-449D-83DE-D497729E7D39Q34647337-1346FC24-0A4C-48E5-9760-FB672A28E6CFQ35166823-A2175720-4183-4C3C-A603-9356BF8DEEFBQ35585364-C87540E5-435B-4A40-9E68-3E9570A14F5AQ35700772-D7C8CE83-12CA-4823-A8A7-4746129853BEQ36803960-EF376218-8CB1-4419-BDCA-B0F3CBFF6A81Q37118510-823CB800-64F8-4D3D-88EC-F61C4CFD18B5Q37156645-10C88EEC-9E76-4EF2-B85C-847D8F581B51Q37374850-ADF71FA2-1A87-4D5E-B17B-FEDB2F4AE0AEQ37650317-D7F05812-8035-4969-BB5C-AAD3529A26D2Q37700546-526A9BCF-9632-48BC-806D-807BB5BB1BE4Q37859397-892F819A-6B0E-4280-8D68-0F4BA20AAFE8Q38711698-78A41738-C032-4849-8704-B26BE437AF7CQ39413843-E8D3D49D-CDB4-496D-9D52-DFD95ECC2EC2Q39610249-67365ADF-37AB-47C1-97CF-3504E5B0F71CQ39899742-27F47241-36FF-4F81-9B41-3764F83F0E3AQ40040786-3ACA04EB-2BB2-4A2A-BAA5-9D8CE4337D10Q40189236-7AA56257-408E-45B7-8FC4-7DC6878B423BQ40692556-77349D52-D745-47F1-AC26-B9EF6EB5E332Q45896960-84CC67BD-8437-4946-B8E5-2E62B526ECB3Q46708620-B6ABB387-1114-4548-B120-65DAD3C88597Q48149197-6AF95E31-F294-45F4-B3F2-45B83F0C0560Q49390751-31E3C250-B716-434C-A347-8C3BB3ACAABEQ51037587-3BC90A09-03BF-4B56-8E28-D5CEAB79AB66Q51174005-E06D786A-974F-4AB2-8719-9A431739C0B3Q52574098-90BF214F-02DC-4C3C-9D3A-6A6D92600654Q57650487-BCA5249B-55B3-4FA7-A154-57E489C63C11
P2860
Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Antifungal susceptibilities of ...... Taiwan program data from 2003
@ast
Antifungal susceptibilities of ...... Taiwan program data from 2003
@en
type
label
Antifungal susceptibilities of ...... Taiwan program data from 2003
@ast
Antifungal susceptibilities of ...... Taiwan program data from 2003
@en
prefLabel
Antifungal susceptibilities of ...... Taiwan program data from 2003
@ast
Antifungal susceptibilities of ...... Taiwan program data from 2003
@en
P2093
P2860
P921
P1476
Antifungal susceptibilities of ...... Taiwan program data from 2003
@en
P2093
Cheng-Yi Liu
Jainn-Ming Shyr
Jen-Hsien Wan
Jing-Jou Yan
Jiunn-Jong Wu
Kwen-Tay Luh
Kwok-Woon Yu
Wen-Chien Ko
Wen-Kuei Huang
Yeu-Jun Lau
P2860
P304
P356
10.1128/AAC.49.2.512-517.2005
P407
P577
2005-02-01T00:00:00Z